BRIDGE THERAPEUTICS
Updated 24 days ago
217 Country Club Park, Ste. 325, Birmingham, AL, 35213
Bridge Therapeutics, Inc. is a development-stage pharmaceutical company pursuing FDA approval of BT‑219 for Opioid Use Disorder (OUD), and BT-205 for the treatment of chronic pain in opioid-experienced patients.
Also known as: Bridge Therapeutics, Inc.